Skip to content

Clinical trials

Bronchiolitis Obliterans Syndrome trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Country / region: Australia Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20091
20102
20122
20133
20142
20155
20161
20175
20182
20191
20201
20211
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Active, not recruiting4
Recruiting3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Pfizer3
Pharmacyclics LLC.3
AstraZeneca2
Gilead Sciences2
Incyte Corporation2
Kirby Institute2
AbbVie1
Abbott Medical Devices1
Aliye Uc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome33
Hepatitis C6
Graft vs Host Disease5
Leukemia3
Lymphoma, Follicular3
Recurrence3
Chronic Urticaria2
Cystic Fibrosis2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.